About the MARKER (complimentary) Effective Size Range: 10kDa to 70kDa. Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa. Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approximation of proteins of inter...
By Dr. C.H. Weaver M.D.Nov 27, 2023 Ovarian Cancer Treatment New Biomarker May be More Effective than CA 125 in Treatment in Ovarian Cancer New Biomarker May be More Effective than CA 125 in Monitoring Treatment Responses in Ovarian Cancer ...
抗体名: CA 125; CA-125; CA125 ovarian cancer antigen; Cancer antigen 125; FLJ14303; MUC16_HUMAN; MUC 16; MUC16; Mucin 16; MUC-16; Mucin 16 cell surface associated; Mucin16; Ovarian cancer related tumor marker CA125; Ovarian carcinoma antigen CA125; Ovarian cancer-related tumor marker ...
Marker half-life was 12 days for the CR group (range 4.5–30 days) and 21 days for the PR group (range 5.5–39 days). Remission duration (r = 0.56) and log cell kill (r = 0.72) were correlated with survival. Combining initial tumour diameter, marker level and NT predicted CR in ...
Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125) Target Species: Human Assay Format Detection Range: 0.6 U/ml - 400 U/ml Recommended Dilution (serum & plasma): 2 fold Sensitivity: 0.6 U/ml Need more sensitivity? Check out the...
Background/Target Information CA125/MUC16 antigen is a serum marker that is used routinely in gynecologic practice to monitor patients with ovarian cancer. It is a mullerian duct differentiation antigen that is overexpressed in epithelial ovarian cancer cells and secreted into the blood, although its...
CA-125 is a tumor marker of ovarian cancer that plays a significant role in making clinical decisions. Many studies assessed the importance of a single CA-125 measurement [7,8,9,10,11,12,13], while number of studies that analyzed the multiple evaluation of this marker is limited. Conductin...
in a trial to assess its value in the diagnosis and follow-up, and to compare it to some prognostic factors.The study included 78 newly diagnosed patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL), with age range 18-60 years, and a WHO performance status of 0, I or II...
Patients received 496 courses of paclitaxel in total (median 6; range: 2–18 courses).RESULTSResponse group numbers on the basis of World Health Organization (WHO) criteria were: 7 partial response, 22 stable disease, and 48 progressive disease. CA 125 values at the moment of clinical ...
(B) Correlation of thrombin time (TT) with CA125. with the disease.37 These indicated that shortened APTT and TT may be associated with hypercoagulation in adeno myosis and increased the risk of thrombosis. CA125, as a mucinous serum marker, expresses in patients with various diseases, ...